Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Norman Djamaluddin"'
Publikováno v:
Asian Pacific Journal of Cancer Care, Vol 8, Iss 2, Pp 435-436 (2023)
Objectives: Gastrointestinal stromal tumor (GIST) is a tumor that is rarely found and is characterized by positive KIT (CD117) and DOG1 results. Multiple myeloma (MM) is characterized by malignant proliferation of uncontrolled plasma cells in the bon
Externí odkaz:
https://doaj.org/article/d6c8e5b9270942768e5f61d4d4071cf9
Publikováno v:
Glioma, Vol 4, Iss 1, Pp 15-18 (2021)
Temozolomide is an orally administered chemotherapeutic drug that has become a standard treatment for malignant gliomas. Severe toxicity of temozolomide is rare, especially shortly after administration. We report a 37-year-old male patient diagnosed
Externí odkaz:
https://doaj.org/article/3520a88d3065449eb012e1c8279450a4
Publikováno v:
Bioscientia Medicina : Journal of Biomedicine and Translational Research. 7:3068-3073
One of the most frequent and significant complicated side effects of myelosuppressive drugs is neutropenia. Neutropenia is not only associated with high morbidity but also mortality. Generally, the onset of neutropenia occurs within 3-7 days after th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d7c5fe8964edd5511bb4eaef200aaa4b
https://doi.org/10.37275/bsm.v7i1.764
https://doi.org/10.37275/bsm.v7i1.764
Publikováno v:
Journal of Medical and Health Studies. 3:71-75
Chemotherapy is the modality of colon cancer therapy that can reduce SCFA levels in the intestine. Probiotics are currently known to have a role in the pathogenesis of colon cancer and adjunct therapy for colon cancer patients. This study aims to exa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b023559e07c23c9a7fb6bf53df0f6e6f
https://doi.org/10.32996/jmhs.2022.3.4.10
https://doi.org/10.32996/jmhs.2022.3.4.10
Publikováno v:
Glioma, Vol 4, Iss 1, Pp 15-18 (2021)
Temozolomide is an orally administered chemotherapeutic drug that has become a standard treatment for malignant gliomas. Severe toxicity of temozolomide is rare, especially shortly after administration. We report a 37-year-old male patient diagnosed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2256dbcc30b30bb38817289c8c18de92
http://www.jglioma.com/article.asp?issn=2589-6113
http://www.jglioma.com/article.asp?issn=2589-6113